Ignite Creation Date:
2024-05-05 @ 7:23 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00666146
Status:
COMPLETED
Last Update Posted:
2021-05-03
First Post:
2008-04-21
Brief Title:
Familial Schizophrenia and Spectrum Personality Disorders
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Familial Schizophrenia and Spectrum Personality Disorders
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We propose to recruit 150 case families ie families with a schizophrenia proband 150 control families and 45 control subjects who exhibit schizophrenia spectrum personality symptoms in the absence of a family history of schizophrenia Participants will undergo a number of clinical electrophysiological perceptual and cognitive assessments These data will be used to identify phenotypes likely to be associated with genetic risk for schizophrenia and to determine how these phenotypes aggregate in families Some of the analyses will focus on examining associations between candidate genes and these alternative phenotypes Thus if we are not able to recruit relatives we may still collect these phenotypic data in probands and their genetic sample for future genotypephenotype association studies Testing procedures require a 10-12 hour time commitment and testing will be completed over 2 or more days Participants will be asked to give a blood or saliva if difficult to obtain blood sample for instance because of fear of blood draws which will be stored for future genetic analyses
Detailed Description:
Specific aims of the proposed study are
1 To test the hypothesis that abnormalities in predictive pursuit antisaccade performance working memory visual attention CPT sensory gating PPI and P50 and other measures of information processing mark the liability for schizophrenia Secondly we will examine the pattern of familial aggregation of these measures to determine whether observed deficits are likely to reflect genetic andor environmental effects The hypothesis will be supported if a the frequency of these neurophysiological deficits is higher in relatives of schizophrenic probands than in relatives of control probands b the prevalence of neurophysiological abnormalities is higher in case relatives with SSP symptoms than in nonSSP case relatives c risk is increased among case relatives of affected probands vs case relatives of unaffected probands ie risk in relatives of case probands who exhibit an abnormality vs relatives of case probands who do not
2 To test the hypothesis that some physiological deficits reflect a common underlying phenotype while others mark independent aspects of disease risk To test this hypothesis a we will examine correlation matrices adjusted for within family correlation for neurophysiological assessments among case relatives and control relatives Factor structures in the two groups will be examined using exploratory factor analyses followed by confirmatory factor analyses using validation samples of casecontrol relatives Confirmatory Factor Analyses CFA will also be used to determine how factor solutions based on casecontrol relatives fit the data of case probands b Factor scores for correlated measures will be derived and the familial risk for composite measures of neurophysiological functioning estimated using the methods described in Specific Aim 1 c Secondary within family analyses will be performed to estimate the heritability of derived factor scores and to determine whether patterns of familial correlations suggest a genetic or environmental cause
3 To evaluate whether particular domains of psychopathology are marked by different putative phenotypic markers We will specifically test the hypotheses that predictive pursuit working memory and sensory gating measures are more strongly associated with positive psychotic symptoms while smooth pursuit initiation and processing speed measures are more strongly associated with primary negative symptoms The relationships between clinical domains and other measures or clusters will be examined in an exploratory hypothesis-generating framework
4 We propose to collect blood samples or rarely saliva sample from each participant to be stored for future association studies as well as formal linkage analyses using phenotypes identified in specific aims 1 and 2
5 We plan to examine how nicotine dependence may run in families and to examine if patterns of nicotine use may be related to a family history of schizophrenia Participants will be asked about their smoking history and current smoking habits Current smokers will be asked more specific questions about their smoking behaviors to estimate level of current nicotine dependence It is hoped that this information will give us clues about why so many individuals with schizophrenia smoke
1 To test the hypothesis that abnormalities in predictive pursuit antisaccade performance working memory visual attention CPT sensory gating PPI and P50 and other measures of information processing mark the liability for schizophrenia Secondly we will examine the pattern of familial aggregation of these measures to determine whether observed deficits are likely to reflect genetic andor environmental effects The hypothesis will be supported if a the frequency of these neurophysiological deficits is higher in relatives of schizophrenic probands than in relatives of control probands b the prevalence of neurophysiological abnormalities is higher in case relatives with SSP symptoms than in nonSSP case relatives c risk is increased among case relatives of affected probands vs case relatives of unaffected probands ie risk in relatives of case probands who exhibit an abnormality vs relatives of case probands who do not
2 To test the hypothesis that some physiological deficits reflect a common underlying phenotype while others mark independent aspects of disease risk To test this hypothesis a we will examine correlation matrices adjusted for within family correlation for neurophysiological assessments among case relatives and control relatives Factor structures in the two groups will be examined using exploratory factor analyses followed by confirmatory factor analyses using validation samples of casecontrol relatives Confirmatory Factor Analyses CFA will also be used to determine how factor solutions based on casecontrol relatives fit the data of case probands b Factor scores for correlated measures will be derived and the familial risk for composite measures of neurophysiological functioning estimated using the methods described in Specific Aim 1 c Secondary within family analyses will be performed to estimate the heritability of derived factor scores and to determine whether patterns of familial correlations suggest a genetic or environmental cause
3 To evaluate whether particular domains of psychopathology are marked by different putative phenotypic markers We will specifically test the hypotheses that predictive pursuit working memory and sensory gating measures are more strongly associated with positive psychotic symptoms while smooth pursuit initiation and processing speed measures are more strongly associated with primary negative symptoms The relationships between clinical domains and other measures or clusters will be examined in an exploratory hypothesis-generating framework
4 We propose to collect blood samples or rarely saliva sample from each participant to be stored for future association studies as well as formal linkage analyses using phenotypes identified in specific aims 1 and 2
5 We plan to examine how nicotine dependence may run in families and to examine if patterns of nicotine use may be related to a family history of schizophrenia Participants will be asked about their smoking history and current smoking habits Current smokers will be asked more specific questions about their smoking behaviors to estimate level of current nicotine dependence It is hoped that this information will give us clues about why so many individuals with schizophrenia smoke
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None